TrialStem cells translational medicine2021

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem/stromal cells.

Liem Thanh Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.